These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11347973)

  • 1. Selective adenosine A2A receptor antagonists.
    Ongini E; Monopoli A; Cacciari B; Baraldi PG
    Farmaco; 2001; 56(1-2):87-90. PubMed ID: 11347973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
    J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
    Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
    J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Ongini E; Dionisotti S; Gessi S; Irenius E; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):7-10. PubMed ID: 9933143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices.
    Latini S; Bordoni F; Corradetti R; Pepeu G; Pedata F
    Br J Pharmacol; 1999 Nov; 128(5):1035-44. PubMed ID: 10556941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
    Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
    J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
    Yang M; Soohoo D; Soelaiman S; Kalla R; Zablocki J; Chu N; Leung K; Yao L; Diamond I; Belardinelli L; Shryock JC
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):133-44. PubMed ID: 17310264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
    Fredholm BB; Lindström K
    Eur J Pharmacol; 1999 Sep; 380(2-3):197-202. PubMed ID: 10513579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
    Koch P; Akkari R; Brunschweiger A; Borrmann T; Schlenk M; Küppers P; Köse M; Radjainia H; Hockemeyer J; Drabczyńska A; Kieć-Kononowicz K; Müller CE
    Bioorg Med Chem; 2013 Dec; 21(23):7435-52. PubMed ID: 24139167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
    Shiozaki S; Ichikawa S; Nakamura J; Kitamura S; Yamada K; Kuwana Y
    Psychopharmacology (Berl); 1999 Nov; 147(1):90-5. PubMed ID: 10591873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal chemistry of A2A adenosine receptor antagonists.
    Cacciari B; Pastorin G; Spalluto G
    Curr Top Med Chem; 2003; 3(4):403-11. PubMed ID: 12570758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptors regulate the extracellular accumulation of excitatory amino acids upon metabolic dysfunction in chick cultured retinal cells.
    Rego AC; Agostinho P; Melo J; Cunha RA; Oliveira CR
    Exp Eye Res; 2000 May; 70(5):577-87. PubMed ID: 10870516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
    Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
    Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
    J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice.
    De Sarro G; De Sarro A; Di Paola ED; Bertorelli R
    Eur J Pharmacol; 1999 Apr; 371(2-3):137-45. PubMed ID: 10357250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
    Baraldi PG; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Romagnoli R; Moorman AR; Varani K; Borea PA; Preti D
    Bioorg Med Chem; 2012 Jan; 20(2):1046-59. PubMed ID: 22204739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.